May 11, 2023: The End of the COVID-19 Pandemic Emergency’s DEA Telemedicine Exemption? “Not So Fast,” Say DEA and SAMHSA
FDA Law Blog
MAY 10, 2023
Palmer — We blogged earlier this week here that DEA is reconsidering its proposed rules for telemedicine prescribing of controlled substances and buprenorphine. 802(54)(G) (which references CMS’s statutory definition of “practice of telemedicine”). 88 Fed. . § 1307.41and 42 C.F.R.
52 
Let's personalize your content